Science Explorer Back to mapMap
Discussion
Company · Tampa · United States

Cvergenx (United States)

cvergenx.comROR OpenAlex
Research works
3
▼ 68% vs 2018-21
Citations
94
32.5 per fractional work
Top-10% rate
41.4%
all institutions 10.0%
Open access
54%
world 40%
International
9%
world 18%
Cvergenx (United States)

Not ranked overall: Cvergenx (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Cvergenx (United States) work in?

In all years, 71% of research at Cvergenx (United States) is in Health Sciences, 25% in Life Sciences. Its largest fields are Medicine (71%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (11%). It does 1.4× the world's share of Health Sciences.

Health Sciences: 2 fractional works · 71.4% of its workMedicine: 2 fractional works · 71.4% of its workLife Sciences: 1 fractional works · 25.0% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 14.3% of its workImmunology and Microbiology: 0 fractional works · 10.7% of its workPhysical Sciences: 0 fractional works · 3.6% of its workMathematics: 0 fractional works · 3.6% of its workALL ITS WORKCvergenx (UnitedStates)3fractional works, all years
Life Sciences25%Physical Sciences4%Health Sciences71%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 4 fields, with their numbers
    1. Medicine271.4%
    1. Biochemistry, Genetics and Molecular Biology014.3%
    2. Immunology and Microbiology010.7%
    1. Mathematics03.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Cvergenx (United States)?

The most cited paper from Cvergenx (United States) is "Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer" (Chi‐Leung Chiang, Kenneth Sik Kwan Chan, Huaping Li et al., 2024), with 14 citations. Next come "Classification of Radiosensitivity Index by Gaussian Mixture Modelling to Inform Radiotherapy Dose and Discover Disease Subclassifications" (1) and "Radiation Therapy Cytotoxicity Score Predicts Optimal Dose and Fractionation for Individual Patients" (1).

Most cited papers
#PaperReleasedCitations
1 Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer Chi‐Leung Chiang, Kenneth Sik Kwan Chan, Huaping Li et al. · Radiotherapy and Oncology 16 Apr 2024 14
2 Classification of Radiosensitivity Index by Gaussian Mixture Modelling to Inform Radiotherapy Dose and Discover Disease Subclassifications Geoffrey Sedor, J.F. Torres-Roca, Mohamed E. Abazeed et al. · International Journal of Radiation Oncology*Biology*Physics Open access Sep 2019 1
3 Radiation Therapy Cytotoxicity Score Predicts Optimal Dose and Fractionation for Individual Patients Jeffrey S. Peacock, C. Li, Xinming Liu et al. · International Journal of Radiation Oncology*Biology*Physics Open access Sep 2019 1
4 Evaluation of Patient and Tumor Features to Optimize Urothelial Metastasis Treatment Aarti Patel, R. Jain, R. Li et al. · International Journal of Radiation Oncology*Biology*Physics Open access 22 Oct 2022 0
5 A Generalizable Competing Hazards Model of Radiation Associated Outcome Assuming Biological Heterogeneity Geoffrey Sedor, J.F. Torres-Roca, Michael W. Kattan et al. · International Journal of Radiation Oncology*Biology*Physics Sep 2019 0
All 8 most cited papers, with filters and sorting

Which research topics does Cvergenx (United States) publish most on?

By volume in 2022-now: Urinary and Genital Oncology Studies, Bladder and Urothelial Cancer Treatments, Ferroptosis and cancer prognosis and Effects of Radiation Exposure.

Urinary and Genital Oncology Studies: 0 fractional worksBladder and Urothelial Cancer Treatments: 0 fractional worksFerroptosis and cancer prognosis: 0 fractional worksEffects of Radiation Exposure: 0 fractional worksEsophageal Cancer Research and Treatment: 0 fractional worksHead and Neck Cancer Studies: 0 fractional works
SurgeryPulmonary and Respiratory MedicineRadiology, Nuclear Medicine and ImagingOtorhinolaryngology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Urinary and Genital Oncology Studies Surgery 0 works
  2. 2 Bladder and Urothelial Cancer Treatments Surgery 0 works
  3. 3 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 0 works
  4. 4 Effects of Radiation Exposure Radiology, Nuclear Medicine and Imaging 0 works
  5. 5 Esophageal Cancer Research and Treatment Surgery 0 works
  6. 6 Head and Neck Cancer Studies Otorhinolaryngology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.9%not open46.1%

World: 40% of research is openly available.

with international co-authors8.6%domestic only91.4%

World: 18% is written across borders.

How has Cvergenx (United States)'s research output changed?

Output in 2022-2025 was 68% lower than in 2018-2021.

201020152020

Other research institutions in Tampa

All research institutions in Tampa

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Cvergenx (United States). Posts are plain text and can be reported.